Prevalence and Factors Associated With Sarcopenia in Pre-retirement Aged Adults With Chronic Non-specific Lower Back Pain

June 6, 2023 updated by: Songsuda Roongsaiwatana, Mahidol University
To study the prevalence of sarcopenia in a pre-retirement group with chronic lower back pain and factors associated between sarcopenia and chronic lower back pain in the pre-retirement group.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

164

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Thailand
      • Bangkok, Thailand, 10400
        • Physical Medicine and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The population included 164 people aged 50 - 59 years.

Description

Inclusion Criteria:

  1. Be a person between the ages of 50 - 59 years with or without chronic lower back pain longer than 3 months, but without any dangerous signs of lower back pain, sciatica pain, and neurological disorder.
  2. Be able to walk continuously for at least 10 minutes.
  3. Give written consent to join the research project.

Exclusion Criteria:

  1. Have a history of spinal fracture, spondylolisthesis, scoliosis, or osteomyelitis.
  2. Have a neurological disorder or myasthenia gravis.
  3. Have a congenital disease such as acute coronary syndrome, cancer, or severe muscular or joint disease that affects the ability to walk continuously for at least 10 meters.
  4. Be implanted with a pacemaker or electrical device.
  5. Refuse or withdraw from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The prevalence of sarcopenia
Time Frame: December2019
participants with or without chronic lower back pain,
December2019

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The associated factors 1
Time Frame: December2019
age
December2019
The associated factors 2
Time Frame: December2019
body mass index
December2019
The associated factors 3
Time Frame: December2019
IPAQ
December2019
The associated factors 4
Time Frame: December2019
EQ-5D-5L
December2019
The associated factors 5
Time Frame: December2019
Congential diseases
December2019
The associated factors 6
Time Frame: December2019
Alcohol drinking
December2019
The associated factors 7
Time Frame: December2019
Cigarette smoking
December2019
The associated factors 8
Time Frame: December2019
Body muscular mass
December2019

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mahidol University

Investigators

  • Study Director: Songsuda Roongsaiwatana, MD, Mahidol University, Ramathibodi Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2019

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

March 30, 2020

Study Registration Dates

First Submitted

April 7, 2023

First Submitted That Met QC Criteria

June 6, 2023

First Posted (Actual)

June 8, 2023

Study Record Updates

Last Update Posted (Actual)

June 8, 2023

Last Update Submitted That Met QC Criteria

June 6, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • COA.MURA2019/733

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe